Principal investigator (PI)
Professor in Clinically Applied Proteomics
Consultant in Hematology and Internal medicine
Science for Life Laboratory, Department of Protein Sciences, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Royal Institute of Technology (KTH)
Clinically applied proteomics
We use high throughput proteomic approaches to study the protein composition of blood plasma from patients with cardiovascular and thromboembolic disorders.
More recently, this has also included patients with COVID-19. The aim is to identify novel protein biomarkers for clinical application in risk prediction, diagnosis and long term prognosis. We are also interested in the study of genetic susceptibility to cardiovascular disease and venous thromboembolism, especially gene regulatory mechanisms and how genetic variation can affect protein expression.
Maria Jesus Iglesias, Senior Researcher
Philip Smith, PhD Student
Jeong Yeon Kim, Post Doc